Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Inventory Average: 2022-2025

Historic Inventory Average for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Sep 2025 value amounting to $19.4 million.

  • Arcutis Biotherapeutics' Inventory Average rose 38.89% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 38.89%. This contributed to the annual value of $13.8 million for FY2024, which is 33.96% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Inventory Average stood at $19.4 million for Q3 2025, which was up 17.62% from $16.5 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Inventory Average high stood at $19.4 million for Q3 2025, and its period low was $5.9 million during Q4 2022.
  • For the 3-year period, Arcutis Biotherapeutics' Inventory Average averaged around $13.6 million, with its median value being $13.6 million (2024).
  • Data for Arcutis Biotherapeutics' Inventory Average shows a peak YoY spiked of 128.80% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Arcutis Biotherapeutics' Inventory Average stood at $5.9 million in 2022, then surged by 128.80% to $13.5 million in 2023, then climbed by 5.52% to $14.3 million in 2024, then spiked by 38.89% to $19.4 million in 2025.
  • Its Inventory Average stands at $19.4 million for Q3 2025, versus $16.5 million for Q2 2025 and $15.6 million for Q1 2025.